117 related articles for article (PubMed ID: 7389352)
1. Early pregnancy interruption with two 15-ME-PGF2a suppositories.
Lauersen NH; Wilson KH
Contraception; 1980 Mar; 21(3):273-82. PubMed ID: 7389352
[TBL] [Abstract][Full Text] [Related]
2. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
Marrs RP; Brenner PF; Roy S; Mishell DR
Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
[TBL] [Abstract][Full Text] [Related]
3. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
4. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
Wan LS; Stiber AJ; Turkel J
Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
[TBL] [Abstract][Full Text] [Related]
5. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
Mandelin M
Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
[TBL] [Abstract][Full Text] [Related]
6. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
Roy S; Brenner PF; Marrs RP; Mishell DR
Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
[TBL] [Abstract][Full Text] [Related]
7. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
[TBL] [Abstract][Full Text] [Related]
8. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
Bygdeman M; Christenssen N; Gréen K; Vesterqvist O; Roseman TJ; Tuttle ME; Spilman CH
Contraception; 1983 Feb; 27(2):141-51. PubMed ID: 6303690
[TBL] [Abstract][Full Text] [Related]
9. The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion.
Lauersen NH; Wilson KH
Adv Prostaglandin Thromboxane Res; 1980; 8():1435-41. PubMed ID: 7376994
[No Abstract] [Full Text] [Related]
10. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
11. [Abortion induction in early pregnancy using prostin F2 alpha and 15(S)-15-methyl PGF 2 alpha].
Seifert B; Liedtke MP; Brockmann J; Beissert M
Zentralbl Gynakol; 1978; 100(19):1266-71. PubMed ID: 716694
[TBL] [Abstract][Full Text] [Related]
12. Early pregnancy interruption with a single PGF2 alpha 15-methyl-analogue vaginal suppository.
Borten M; Friedman EA
J Reprod Med; 1985 Oct; 30(10):741-4. PubMed ID: 3877806
[TBL] [Abstract][Full Text] [Related]
13. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
Smith SK; Baird DT
Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
[TBL] [Abstract][Full Text] [Related]
14. Treatment with a single vaginal suppository containing 15-methyl PGF2 alpha methyl ester at expected time of menstruation.
Kinoshita K; Eneroth P; Bygdeman M
Prostaglandins; 1979 Mar; 17(3):469-81. PubMed ID: 472340
[TBL] [Abstract][Full Text] [Related]
15. Outpatient postconceptional fertility control with vaginally administered 15(S) 15-methyl-PGF2alpha-methyl ester.
Bygdeman M; Martin JN; Eneroth P; Leader A; Lundström V
Am J Obstet Gynecol; 1976 Mar; 124(5):495-8. PubMed ID: 1258906
[TBL] [Abstract][Full Text] [Related]
16. Postconceptional induction of menses with double prostaglandin F2 alpha impact.
Borten M; Friedman EA
Am J Obstet Gynecol; 1984 Dec; 150(8):1006-7. PubMed ID: 6507528
[TBL] [Abstract][Full Text] [Related]
17. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
Roux JF; Southern E; Gutknecht G
Contraception; 1980 Jul; 22(1):57-61. PubMed ID: 7418407
[TBL] [Abstract][Full Text] [Related]
18. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
[TBL] [Abstract][Full Text] [Related]
19. Early pregnancy-abortion model using sulprostone.
Fleischer A; Schulman H; Blattner P; Jagani N; Fayemi A
Prostaglandins; 1982 May; 23(5):643-55. PubMed ID: 7122906
[TBL] [Abstract][Full Text] [Related]
20. Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1983 Aug; 28(2):111-24. PubMed ID: 6196152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
